BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32555380)

  • 21. Kaposi's sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages.
    Bhaskaran N; Ghosh SK; Yu X; Qin S; Weinberg A; Pandiyan P; Ye F
    Cell Cycle; 2017; 16(17):1611-1621. PubMed ID: 28750175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral interleukin-6 encoded by an oncogenic virus promotes angiogenesis and cellular transformation by enhancing STAT3-mediated epigenetic silencing of caveolin 1.
    Li W; Wang Q; Qi X; Guo Y; Lu H; Chen Y; Lu Z; Yan Q; Zhu X; Jung JU; Tosato G; Gao SJ; Lu C
    Oncogene; 2020 Jun; 39(23):4603-4618. PubMed ID: 32393833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
    Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
    Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
    Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1.
    Shin YC; Nakamura H; Liang X; Feng P; Chang H; Kowalik TF; Jung JU
    J Virol; 2006 Mar; 80(5):2257-66. PubMed ID: 16474133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes.
    DiMaio TA; Gutierrez KD; Lagunoff M
    PLoS Pathog; 2011 Dec; 7(12):e1002424. PubMed ID: 22174684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection.
    Lee MS; Jones T; Song DY; Jang JH; Jung JU; Gao SJ
    PLoS Pathog; 2014 Sep; 10(9):e1004412. PubMed ID: 25254972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
    Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the DNA sequence interacting with Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 1.
    Park J; Lee MS; Yoo SM; Jeong KW; Lee D; Choe J; Seo T
    J Virol; 2007 Nov; 81(22):12680-4. PubMed ID: 17855527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.
    He M; Zhang W; Bakken T; Schutten M; Toth Z; Jung JU; Gill P; Cannon M; Gao SJ
    Cancer Res; 2012 Jul; 72(14):3582-92. PubMed ID: 22593192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis.
    Gallaher AM; Das S; Xiao Z; Andresson T; Kieffer-Kwon P; Happel C; Ziegelbauer J
    PLoS Pathog; 2013; 9(9):e1003584. PubMed ID: 24039573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus.
    Dai L; Qiao J; Nguyen D; Struckhoff AP; Doyle L; Bonstaff K; Del Valle L; Parsons C; Toole BP; Renne R; Qin Z
    Oncotarget; 2016 Mar; 7(9):10459-71. PubMed ID: 26859574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.
    Seo T; Lee D; Shim YS; Angell JE; Chidambaram NV; Kalvakolanu DV; Choe J
    J Virol; 2002 Sep; 76(17):8797-807. PubMed ID: 12163600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses.
    Ma Z; Jacobs SR; West JA; Stopford C; Zhang Z; Davis Z; Barber GN; Glaunsinger BA; Dittmer DP; Damania B
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):E4306-15. PubMed ID: 26199418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.
    Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B
    PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiting the Recruitment of PLCγ1 to Kaposi's Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial Cells.
    Gramolelli S; Weidner-Glunde M; Abere B; Viejo-Borbolla A; Bala K; Rückert J; Kremmer E; Schulz TF
    PLoS Pathog; 2015 Aug; 11(8):e1005105. PubMed ID: 26295810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway.
    Lee HR; Toth Z; Shin YC; Lee JS; Chang H; Gu W; Oh TK; Kim MH; Jung JU
    J Virol; 2009 Jul; 83(13):6739-47. PubMed ID: 19369353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.
    Qian LW; Xie J; Ye F; Gao SJ
    J Virol; 2007 Jul; 81(13):7001-10. PubMed ID: 17442715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma.
    Croci DO; Salatino M; Rubinstein N; Cerliani JP; Cavallin LE; Leung HJ; Ouyang J; Ilarregui JM; Toscano MA; Domaica CI; Croci MC; Shipp MA; Mesri EA; Albini A; Rabinovich GA
    J Exp Med; 2012 Oct; 209(11):1985-2000. PubMed ID: 23027923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.
    Ojala PM; Schulz TF
    Semin Cancer Biol; 2014 Jun; 26():69-77. PubMed ID: 24486643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.